1. L. Konstantinidis, I. Mantel, J-Antoine C. Pournaras et.a. Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization. Greafes Arch Clin Exp Ophthalmol 2009 247: 311-318
  2. W-Mai Chan, Timothy Y, Y.Lai et al. Intravitreal Bevacizumab (Avastin) for Myopic Choroidal Neovascularization Six-Month Results of a Prospective Pilot Study. Ophthalmology 2007114:2190-2196
  3. T.Yoshida, K. ohno-Matsui, K. Yasuzumi Myopic Choroidal Neovascularization A 10-year Follow-up. Ophthalmology 2003 110:1297-1305
  4. T.Yoshida, K. ohno-Matsui, K. Yasuzumi Long term Visual Prognosis of Choroidal Neovascularization in High Myopia A Comparison between Age Groups. Ophthalmology 2002 109:712-719
  5. G. Virgili, M. Varano, G. Giacomelli Photodynamic Therapy for Nonsubfoveal Choroidal Neovascularization in 100 Eyes With Pathologic Myopia American Journal of Ophthalmology 2007 143:77-82
  6. Chauvaud D. A blinding orphan disease: high myopia. Bull Acad Natl Med. 2005 5:867-872

Suggested Reading

  1. G. Soubrane Choroidal Neovascularization in Pathologic Myopia: Recent Developments in Diagnosis and Treatment. Survey of Ophthalmology 2008 53:121-138